These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
311 related articles for article (PubMed ID: 32648508)
1. Postimplant Phosphodiesterase Type 5 Inhibitors Use Is Associated With Lower Rates of Thrombotic Events After Left Ventricular Assist Device Implantation. Xanthopoulos A; Tryposkiadis K; Triposkiadis F; Fukamachi K; Soltesz EG; Young JB; Wolski K; Blackstone EH; Starling RC J Am Heart Assoc; 2020 Jul; 9(14):e015897. PubMed ID: 32648508 [TBL] [Abstract][Full Text] [Related]
2. Postimplant Phosphodiesterase-5 Inhibitor Use in Centrifugal Flow Left Ventricular Assist Devices. Xanthopoulos A; Wolski K; Wang Q; Blackstone EH; Randhawa VK; Soltesz EG; Young JB; Nissen SE; Estep JD; Triposkiadis F; Starling RC JACC Heart Fail; 2022 Feb; 10(2):89-100. PubMed ID: 35115092 [TBL] [Abstract][Full Text] [Related]
3. Reduction of Adverse Events With Phosphodiesterase 5 Inhibitors Post LVAD Implantation: Is It Time for a Randomized Trial? Starling RC; Xanthopoulos A; Nissen SE; Triposkiadis F J Card Fail; 2022 Dec; 28(12):1733-1737. PubMed ID: 35690316 [TBL] [Abstract][Full Text] [Related]
4. Left ventricular assist device outcomes based on flow configuration and pre-operative left ventricular dimension: An Interagency Registry for Mechanically Assisted Circulatory Support Analysis. Shah P; Birk S; Maltais S; Stulak J; Elmi A; Pagani FD; Cowger JA J Heart Lung Transplant; 2017 Jun; 36(6):640-649. PubMed ID: 28087105 [TBL] [Abstract][Full Text] [Related]
5. Effect of phosphodiesterase type 5 inhibitors on major adverse cardiovascular events and overall mortality in a large nationwide cohort of men with erectile dysfunction and cardiovascular risk factors: A retrospective, observational study based on healthcare claims and national death index data. Kloner RA; Stanek E; Crowe CL; Singhal M; Pepe RS; Bradsher J; Rosen RC J Sex Med; 2023 Jan; 20(1):38-48. PubMed ID: 36897243 [TBL] [Abstract][Full Text] [Related]
9. What is the optimal anticoagulation in patients with a left ventricular assist device? Rossi M; Serraino GF; Jiritano F; Renzulli A Interact Cardiovasc Thorac Surg; 2012 Oct; 15(4):733-40. PubMed ID: 22761118 [TBL] [Abstract][Full Text] [Related]
10. Management of Antiplatelet Therapy During Continuous-Flow Left Ventricular Assist Device Support After Thrombotic Hemorrhagic Events. Gallo M; Trivedi JR; Mondal NK; Birks EJ; Slaughter MS ASAIO J; 2019; 65(7):683-689. PubMed ID: 30585872 [TBL] [Abstract][Full Text] [Related]
11. INTERMACS Analysis of Stroke During Support With Continuous-Flow Left Ventricular Assist Devices: Risk Factors and Outcomes. Acharya D; Loyaga-Rendon R; Morgan CJ; Sands KA; Pamboukian SV; Rajapreyar I; Holman WL; Kirklin JK; Tallaj JA JACC Heart Fail; 2017 Oct; 5(10):703-711. PubMed ID: 28958345 [TBL] [Abstract][Full Text] [Related]
12. Increased Rate of Pump Thrombosis and Cardioembolic Events Following Ventricular Tachycardia Ablation in Patients Supported With Left Ventricular Assist Devices. Grinstein J; Garan AR; Oesterle A; Fried J; Imamura T; Mai X; Kalantari S; Sayer G; Kim GH; Sarswat N; Raikhelkar J; Adatya S; Jeevanandam V; Flatley E; Moss J; Uriel N ASAIO J; 2020; 66(10):1127-1136. PubMed ID: 33136600 [TBL] [Abstract][Full Text] [Related]
13. Dynamic Forecasts of Survival for Patients Living With Destination Left Ventricular Assist Devices: Insights From INTERMACS. Michelis KC; Zhong L; Peltz M; Pandey A; Tang WHW; Rohatgi A; Young JB; Drazner MH; Grodin JL J Am Heart Assoc; 2020 Jul; 9(14):e016203. PubMed ID: 32648531 [TBL] [Abstract][Full Text] [Related]
14. Antithrombotic therapy for left ventricular assist devices in adults: a systematic review. Baumann Kreuziger LM; Kim B; Wieselthaler GM J Thromb Haemost; 2015 Jun; 13(6):946-55. PubMed ID: 25845489 [TBL] [Abstract][Full Text] [Related]
15. Stroke outcomes following durable left ventricular assist device implant in patients bridged with micro-axial flow pump: Insights from a large registry. Gallone G; Lewin D; Rojas Hernandez S; Bernhardt A; Billion M; Meyer A; Netuka I; Kooij JJ; Pieri M; Szymanski MK; Moeller CH; Akhyari P; Jawad K; Krasivskyi I; Schmack B; Färber G; Medina M; Haneya A; Zimpfer D; Nersesian G; Lanmueller P; Spitaleri A; Oezkur M; Djordjevic I; Saeed D; Boffini M; Stein J; Gustafsson F; Scandroglio AM; De Ferrari GM; Meyns B; Hofmann S; Belohlavek J; Gummert J; Rinaldi M; Potapov EV; Loforte A Artif Organs; 2024 Oct; 48(10):1168-1179. PubMed ID: 38803239 [TBL] [Abstract][Full Text] [Related]
16. Early Aspirin Nonresponders Identification by Routine Use of Aggregometry Test in Patients With Left Ventricle Assist Devices Reduces the Risk of Pump Thrombosis. Montalto A; Comisso M; Cammardella A; Nicolò F; Gherli R; Palermo A; Pulcinelli F; Musumeci F Transplant Proc; 2019 Nov; 51(9):2986-2990. PubMed ID: 31711580 [TBL] [Abstract][Full Text] [Related]